AnalystsSean McCutcheonSean McCutcheon's Stock Forecasts
AnalystsSean McCutcheon
Sectors:
Industries:
Analyst Ranking
Bottom 15%
#4351 out of 5077 analysts
Average Return
-4.46%
Win Rate
45%5 out of 11
Risk vs Reward
Poor
Good
Sean McCutcheon's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Black Diamond Therapeutics IncBDTX | +58.47% | $2.48 | $3.93 | 2025-07-01 - 2025-10-24 | Buy |
Compass Therapeutics IncCMPX | +53.88% | $2.58 | $3.97 | 2025-07-01 - 2025-10-24 | Buy |
Revolution Medicines IncRVMD | +17.04% | $46.55 | $54.48 | 2025-09-12 - 2025-10-24 | Strong Buy |
Vir Biotechnology IncVIR | +5.84% | $5.65 | $5.98 | 2025-07-11 - 2025-10-24 | Buy |
Revolution Medicines IncRVMD | +0.70% | $54.10 | $54.48 | 2025-10-17 - 2025-10-24 | Strong Buy |
Sean McCutcheon Analyst Color
Get additional color on Sean McCutcheon's coverage of popular stocks
Sean McCutcheon's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Revolution Medicines IncRVMD | 2 | Strong Buy | $76.00 | +39.50% | Maintains | 9 days ago |
Vir Biotechnology IncVIR | 1 | Buy | $12.00 | +100.67% | Initiates Coverage On | 3 months ago |
Janux Therapeutics IncJANX | 1 | Buy | $65.00 | +161.04% | Initiates Coverage On | 3 months ago |
Compass Therapeutics IncCMPX | 1 | Buy | $9.00 | +126.70% | Reinstates | 4 months ago |
Black Diamond Therapeutics IncBDTX | 1 | Buy | $11.00 | +179.90% | Reinstates | 4 months ago |
Engene Holdings IncENGN | 1 | Buy | $23.00 | +178.28% | Initiates Coverage On | a year ago |
Xencor IncXNCR | 1 | Strong Buy | $40.00 | N/A | Maintains | a year ago |
Cytokinetics IncCYTK | 2 | Buy | $70.00 | N/A | Maintains | a year ago |
Legend Biotech CorpLEGN | 1 | Buy | $86.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.